Staphylococcus aureus is commonly associated with chronic infections, particularly 66 of the skin and soft tissue [1, 2] . It will typically form sessile communities known as 67 biofilms which are associated with increased tolerance to antimicrobials. Biofilms are 68 highly heterogeneous, containing cellular sub-populations that are non-dividing 69 and/or are metabolically inactive. As a large proportion of clinically administered 70 antimicrobials target actively dividing cells this adopted quiescent state renders 71 these antimicrobials ineffective, thus allowing biofilm bacteria to survive therapeutic 72 intervention and contribute to chronic disease [3] . S. aureus has also evolved 73 resistance towards common antimicrobials including β-lactams and glycopeptides, 74 such as vancomycin (MRSA and VRSA, respectively)[4]; a trait which may be linked 75 to increased horizontal gene transfer between bacteria residing in biofilms [5, 6] . As a 76 result of these tolerance and resistance mechanisms, ineffective treatment regimens 77 can create environments that favour the selection of further antimicrobial resistance, 78 making chronic infections even more difficult to treat [7] . As such, the development of 79 novel antimicrobials targeting biofilm bacteria is highly desirable. 80 81 HT61 is a quinoline derivative that has demonstrated efficacy against both dividing 82 and non-dividing planktonic cultures of Staphylococcal spp., with no detectable 83 5 91
In this study, we investigated the efficacy of HT61 against established in vitro S. 92 aureus biofilms. We also utilised a quantitative label-free proteomic approach to 93 identify changes in protein expression following treatment with sub-inhibitory and 94 inhibitory concentrations in order to elucidate cellular processes linked to HT61's 95 mechanism of action. 96 97 2. Materials and Methods 98
Bacterial strains and growth conditions 99
S. aureus UAMS-1, a methicillin sensitive osteomyelitis isolate [11] , was used for all 100 experiments and grown in tryptic soy broth (TSB, Oxoid, UK) at 37 °C and 120 rpm 101 (planktonic) or 50 rpm (biofilm). All inocula were performed with a starting density of 102 10 5 cells ml -1 . Biofilm cultures were performed in Nunc-coated 6 well plates, 103 (Thermo-Fisher, UK) for susceptibility testing and proteomics, poly-L-lysine coated 104 glass bottom dishes (MatTek, USA) for confocal laser scanning microscopy (CLSM), 105 and glass cover slips in Nunc-coated 6 well plates for scanning electron microscopy 106 (SEM). All biofilms were grown for 72 hours, with spent media replaced with fresh 107 TSB every 24 hours. 108 6 tryptic soy agar (TSA), prior to incubation at 37 °C and colony forming unit (cfu) 116 enumeration. Biofilm MBCs were calculated as per Howlin et al (2015) [12] . Firstly, 117 biofilms were grown as described in 2.1. Following 72 hours, spent media was 118 replaced with medium containing either HT61 or vancomycin at the designated 119 concentrations and biofilms were incubated for an additional 24 hours. The media 120 was discarded and the biofilms rinsed twice with HBSS to remove non-adhered cells. 121
Biofilms were detached using a cell scraper and suspended in 1 ml of HBSS. 
Protein Extraction 149
The cellular response of S. aureus to HT61 was determined using label-free ultra-150 performance liquid chromatography mass spectrometry Elevated Energy , (UPLC/MS E ). 151
Planktonic cultures were grown to stationary phase in TSB for 12 hours at 37 °C with 152 either 0, 4 or 16 mg/L HT61 (sub-MIC and MIC, respectively) then centrifuged at 153 2500 x g for 15 minutes. Biofilms were cultured for 72 hours in Nunc-coated 6 well 154 plates as described in 2.1. After 72 hours, media was replaced with TSB 155 supplemented with 0, 4 or 16 mg/L HT61 and incubated for 12 hours at 37 °C. 156
Biofilms were rinsed twice using HBSS, scraped from the surface of the plate and with a false discovery rate (FDR) ≤ 1% and sequence coverage ≥ 5%. Differential 218 expression was categorised by an expression rate of ≥ 1.5 and ≤ 0.667 with p ≤ 0.05 219 using a one-tailed student t-test. Proteins were analysed using a combination of 220 uniprot database searches (www.uniprot.org, accessed between 01/05/18 and 221 07/07/18) and gene ontology analysis using GeoPANTHER [17] . 222
Results 223

HT61 is more effective than vancomycin towards S. aureus biofilms 224
The efficacy of HT61 and vancomycin towards planktonic and biofilm cultures of S. 225 aureus was compared ( Table 1) Table S1 ). Of the proteins that were differentially 262 expressed the majority were involved in metabolic processes, representing 46.7% of 263 proteins increased in expression and 25.8% of proteins decreased in expression 264 (see Table S2 ). All proteins identified as part of the TCA cycle were significantly 265 upregulated, (9/9, average 4.99-fold increase, with CitZ citrate synthase upregulated 266 11.95-fold). Conversely, all identified proteins associated with fatty acid metabolism 267 (Table 2) . HT61 treatment resulted in the differential 290 expression of proteins involved in a variety of functions including cell wall 291 biosynthesis, DNA synthesis, and metabolism (see Tables S3 and S4) . FemB, which are required for peptidoglycan crosslinking (2.53 mean fold increase) 300 and a 2.19 fold upregulation of VraR, the regulator of the CWS stimulon [20] . 301 302 DNA synthesis in planktonic cultures was also affected by HT61 treatment (Table 3) . Biofilms treated with HT61 presented with a similar, albeit more muted response 318 (Table 2) . When treated with HT61 at 16 mg/L increased expression was observed 319 for both MurD (1.59 fold) and PcrA (2.13 fold), similar to planktonic cultures (Table  320 3). Unlike HT61 treated planktonic cultures, proteins associated with the cell cycle 321
were not differentially expressed in HT61 treated biofilms. 322
HT61 treatment affects cellular metabolism and translation 323
Sub-MIC HT61 treatment of planktonic cultures was associated with increased 324 expression of components of the ADI pathway (ArcA, ArcC) and ArgF (1.93 mean 325 fold increase). However, increasing the HT61 concentration resulted in these 326 proteins returning to basal expression, but led to other significant changes in cellular 327 metabolism. These included decreased expression of two TCA cycle components 328 (succinate dehydrogenase SdhA, and citrate synthase CitZ) and six proteins 329 associated with glycolysis/gluconeogenesis. Conversely, there was upregulation of 330 proteins linked to fatty acid metabolism (80%, 4/5), as well as other miscellaneous 331 metabolic processes (see Table S3 ). Curiously, when utilised at its MIC, HT61 332 treatment of planktonic cultures led to the upregulation of 5 proteins linked to tRNA 333 modification. All proteins were upregulated more than two-fold, with MnmG and 334 YqeV upregulated 3.65 and 7.32 fold, respectively. tRNA modifications alter tRNA 335 base specificity and alter translational output [23] . 336
Discussion 337
The dormant populations of bacteria residing within biofilms are a major contributing 338 factor towards the enhanced antimicrobial tolerance associated with this phenotype, 339 and also serve as a potential driver for the development of AMR 3 . Targeting these 340 populations therefore offers a route to treating biofilm-associated chronic infections 341 and reducing the spread AMR. Previous studies have shown that the quinoline 342 derivative, HT61, was effective in treating non-dividing planktonic staphylococcal 343 spp., thereby making it an ideal candidate for the treatment of S. aureus biofilms 8-10 . 344
345
To determine whether HT61 would be more effective than an antibiotic that targets 346 actively dividing cells we compared its activity to vancomycin, for which the 347 mechanism of action necessitates active cell wall turnover [24] . Whilst vancomycin 348 was more effective than HT61 against planktonic S. aureus its efficacy was reduced 349 against the biofilm phenotype, evidencing the enhanced tolerance which can be 350 attributed to the presence of a dormant subpopulation. HT61, however, was more 351 effective than vancomycin at treating established S. aureus biofilms, confirming that 352 its activity against non-dividing cells confers an advantage against this phenotype. In conclusion, we have demonstrated that HT61 is more effective than vancomycin in 406 treating S. aureus biofilms by virtue of its ability to target dormant subpopulations, 407 and therefore represents a potential treatment for chronic S. aureus biofilm 408 infections. Using a quantitative proteomic approach, we have also shown that HT61 409 can influence the expression of the CWS stimulon and dcw cluster. By identifying 410 cellular processes that altered following HT61 treatment, we suggest that they may 411 provide novel antimicrobial targets and could inform the development of future 412 antimicrobial compounds and therapeutic strategies. 
Figure 4:
Overview of differential protein expression between planktonic and biofilm cultures of S. aureus. Number of proteins identified for each category is displayed in brackets. For quantitative analysis the following selection criteria were set: proteins present in all three biological replicates, FDR of £ 1%, and sequence coverage of ³ 5%. Proteins were classed as differentially expressed at ³ 1.5 for increased expression or £ 0.667 for decreased expression, p £ 0.05. Functional categories were assigned using GeoPANTHER and UniProt database searches. Table 3 : Differentially expressed proteins associated with the dcw and cell wall stimulon in S. aureus following treatment of planktonic cultures with HT61. Expression ratios reflect changes in expression between untreated cultures and those treated with either sub-MIC (4 mg/L) or MIC (16 mg/L) concentrations of HT61. Differential expression in biofilms indicated in brackets. Differential expression is defined as a fold change ≥ 1.5 for upregulation (green cells) and ≤ 0.667 for down regulation (red cells). Grey cells indicate no change in expression. Empty cells -proteins not identified. 
